Related Experiment Video

Updated: Aug 9, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Are we aggressive enough in lowering cholesterol?

D D Waters1

  • 1Cardiology Division, Department of Medicine, San Francisco General Hospital, San Francisco, California 94110, USA. dwaters@medsfgh.ucsf.edu

The American Journal of Cardiology
|August 25, 2001
PubMed

Insights

Statin therapy significantly reduces mortality and major coronary events by lowering low-density lipoprotein cholesterol (LDL-C). Lowering cholesterol levels, regardless of baseline, is crucial for cardiovascular risk reduction in broad patient populations.

Area of Science:

  • Cardiology
  • Pharmacology
  • Preventive Medicine

Background:

  • Epidemiological studies consistently show a correlation between lower cholesterol levels and reduced cardiovascular risk.
  • Statin medications are widely used to manage cholesterol levels.

Purpose of the Study:

  • To evaluate the efficacy of statin therapy in reducing mortality and major coronary events.
  • To assess the impact of lowering low-density lipoprotein cholesterol (LDL-C) on cardiovascular outcomes.

Main Methods:

  • Analysis of data from five major randomized, placebo-controlled statin trials.
  • Inclusion of diverse patient groups, including those with and without pre-existing coronary artery disease and varying LDL-C levels.

Main Results:

  • Statin therapy significantly reduced total mortality and major coronary events across all patient groups.
  • Consistent evidence supports a direct relationship between lower LDL-C levels and decreased cardiovascular risk.

Conclusions:

  • Aggressively targeting LDL-C reduction with statins is strongly supported for both primary and secondary prevention of coronary disease.
  • The findings reinforce the importance of statin therapy in managing cardiovascular health.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay08:18

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...